Discuss all risks and benefits with your doctor, especially if you are pregnant, breastfeeding, or have a history of heart, kidney, or electrolyte disorders
5-Amino-1MQ is sold for laboratory research use only
personal fees for lectures and consultancy fees (paid to his institution) from Boehringer Ingelheim, Eli Lilly, Janssen, Mundipharma, Napp, Sanofi, and Takeda
What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
The enzyme also keeps mitochondria efficient and helps it perform under stress